1. Death rates in the U.S. due to Leukodystrophies with pediatric forms
- Author
-
Adeline Vanderver, Amy Barczykowski, Randy L. Carter, Thomas J. Langan, and Kabir Jalal
- Subjects
0301 basic medicine ,Data Analysis ,medicine.medical_specialty ,Population ,030105 genetics & heredity ,History, 21st Century ,03 medical and health sciences ,Cause of Death ,Epidemiology ,Genetics ,medicine ,Prevalence ,Humans ,Mortality ,education ,Genetics (clinical) ,Cause of death ,Newborn screening ,education.field_of_study ,business.industry ,Mortality rate ,Age specific mortality ,Age Factors ,Pediatric Death ,Leukodystrophy, Metachromatic ,History, 20th Century ,United States ,030104 developmental biology ,Population Surveillance ,Death certificate ,business ,Algorithms ,Demography - Abstract
To use national mortality and state death certificate records to estimate disease specific mortality rates among pediatric and adult populations for 23 leukodystrophies (LDs) with pediatric forms. Additionally, to calculate yearly prevalence and caseload of the most severe LD cases that will eventually result in pediatric death (i.e., pediatric fatality cases). Death certificate records describing cause of death were collected from states based on 10 ICD-10 codes associated with the 23 LDs. Deaths in the U.S. with these codes were distributed into categories based on proportions identified in state death certificate data. Mortality rates, prevalence, and caseload were calculated from resulting expected numbers, population sizes, and average lifetimes. An estimated 1.513 per 1,000,000 0-17 year old's died of these LDs at average age 5.2 years and 0.194 for those ≥18 at an average age of 42.3 years. Prevalence of pediatric fatality cases of these LDs declined from 1999 through 2007 and then remained constant at 6.2 per million children per year through 2012. Epidemiological information, currently lacking for rare diseases, is useful to newborn screening programs, research funding agencies, and care centers for LD patients. Methods used here are generally useful for studying rare diseases.
- Published
- 2021